| Development, validation, and application of a novel 7-day Caco-2 cell culture system Y Cai, C Xu, P Chen, J Hu, R Hu, M Huang, H Bi Journal of pharmacological and toxicological methods 70 (2), 175-181, 2014 | 51 | 2014 |
| CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose‐adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post‐Kidney … R Hu, DT Barratt, JK Coller, BC Sallustio, AA Somogyi Basic & clinical pharmacology & toxicology 123 (3), 320-326, 2018 | 31 | 2018 |
| Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal … BC Sallustio, BD Noll, R Hu, DT Barratt, J Tuke, JK Coller, GR Russ, ... British Journal of Clinical Pharmacology 87 (10), 3901-3909, 2021 | 28 | 2021 |
| Genotype-guided warfarin dosing in patients with mechanical valves: a randomized controlled trial Z Xu, S Zhang, M Huang, R Hu, J Li, H Cen, Z Wang, J Ou, S Yin, Y Xu, ... The Annals of thoracic surgery 106 (6), 1774-1781, 2018 | 23 | 2018 |
| Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase J Shen, R Hu, A Lin, A Jiang, B Tang, Z Liu, Q Cheng, K Miao, J Zhang, ... EClinicalMedicine 73, 2024 | 10 | 2024 |
| Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation R Hu, DT Barratt, JK Coller, BC Sallustio, AA Somogyi Pharmacogenetics and Genomics 29 (1), 9-17, 2019 | 10 | 2019 |
| Is there a temporal relationship between trough whole blood tacrolimus concentration and acute rejection in the first 14 days after kidney transplantation? R Hu, DT Barratt, JK Coller, BC Sallustio, AA Somogyi Therapeutic drug monitoring 41 (4), 528-532, 2019 | 8 | 2019 |
| Knowledge map of thrombopoietin receptor agonists: a bibliometric analysis R Hu, S Guo, M Liu Heliyon 10 (1), 2024 | 5 | 2024 |
| No major effect of innate immune genetics on acute kidney rejection in the first 2 weeks post-transplantation R Hu, DT Barratt, JK Coller, BC Sallustio, AA Somogyi Frontiers in Pharmacology 10, 1686, 2020 | 4 | 2020 |
| Exploration of treatment in childhood Langerhans cell histiocytosis based on inflammatory and malignant symptoms: a pilot study H Lin, Q Zheng, R Huang, R Hu, X Liu, J Wang Orphanet Journal of Rare Diseases 19 (1), 174, 2024 | | 2024 |
Andrew SomogyiUniversity of Adelaide, Discipline of PharmacologyПодтвержден адрес электронной почты в домене adelaide.edu.au